Induction of Labor in Term Pregnancies With Unfavourable Cervix

NCT04280874 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Induction of Labor Affected Fetus / Newborn
Prostaglandins Causing Adverse Effects in Therapeutic Use

Interventions

DRUG: Dinoprostone 0.5 MG
DRUG: Dinoprostone 2 MG/2.5 ML Vaginal Gel/Jelly

Sponsor

Clinical Hospital Merkur